Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ABRILIA 20 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ABRILIA 20 MG COMPRIMIDOS EFG

Approved

STANDARD

ABRILIA 20 MG COMPRIMIDOS EFG

Laboratorios Normon S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 16, 2020
Approval ID: 347414a3309dd7da
Company: Laboratorios Normon S.A.
Type: Standard

Approval Details

Approval Id: 347414a3309dd7da
Drug Cima Aemps Name: ABRILIA 20 MG COMPRIMIDOS EFG
Register Number: 85180
Holder Company Name: Laboratorios Normon S.A.
Marketing Company Name: Laboratorios Normon S.A.
Authorization Date: 2020-06-16
Dosage Form: COMPRIMIDO
Dose: 20 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Laboratorios Normon S.A.

Active Ingredients

BILASTINA

20 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 16, 2020

Approval ID

347414a3309dd7da

Type

Standard

Back to CIMA-AEMPS Approvals